Orphan Drugs: FDA January 2015 Approvals
The chart below identifies Orphan Drugs receiving FDA January 2015 approval as of 02/04/15 in ascending “Approval Date” order.
FDA January 2015 Orphan Products Receiving Approval
|#||Generic Name/Approval Date||Sponsor Company||Indication|
|1||Levodopa & Carbidopa(Duopa)/ 01.09||AbbVie||Motor flucuations in patients with advanced Parkinson’s disease|
|2||Parathyroid Hormone (Natpara)/ 01.23||NPS Pharmaceuticals||Adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism|
Copyright © 2012-2015, Orphan Druganaut Blog. All rights reserved.